Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions - PubMed (original) (raw)

Comparative Study

Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions

Jasmina B Mackic et al. Vascul Pharmacol. 2002 Jun.

Abstract

1. We studied cerebrovascular sequestration and blood-brain barrier (BBB) permeability to [125I]- or [123I]-labeled amyloid-beta peptides (A beta) in aged rhesus and aged squirrel monkey, the nonhuman primate models of cerebral beta-amyloidosis and cerebrovascular amyloid angiopathy (CAA), respectively. 2. In aged rhesus, the half-time of elimination of [125I]A beta 1-40, t1/2e, was faster by 1.34 h, the systemic clearance, Clss, increased by 4.21 ml/min/kg and the mean residence time of intact peptide in the circulation shortened by 2 h. 3. Cerebrovascular sequestration of [125I]A beta 1-40 was significant in aged squirrel monkey (20.8 ml/g x 10(2)), but undetectable in the rhesus. 4. The permeability surface area product, PS, for [14C]inulin was low in both species (0.11-0.18 ml/g/s x 10(6)) indicating an intact barrier. 5. The BBB permeability to A beta 1-40 was 34.8- and 13.7-fold higher than for [14C]inulin in aged squirrel and rhesus, respectively, suggesting a specialized A beta transport across the BBB. 6. The single photon computed emission tomography studies confirmed a saturable [123I]A beta 1-40 transport at the BBB in primates (Km = 40 nM). 7. Brain autoradiographic analysis of [125I]A beta 1-42 or [125I]A beta 1-40 after intracarotid infusions of radiotracers confirmed co-localization of the signal with A beta-immunoreactive plaques in rhesus monkeys. 8. Metabolism of [125I]A beta 1-40 in brain and plasma was slower in aged squirrel compared to aged rhesus, by 2.9- and 2.6-fold, respectively. 9. Thus, transport of circulating A beta across the BBB contributes to brain parenchymal accumulation of amyloid in aged nonhuman primates. Negligible capillary binding, rapid systemic and brain degradation, and accelerated body elimination of blood-borne A beta, may prevent the development of CAA in rhesus in contrast to squirrel monkeys.

PubMed Disclaimer

Cited by

One immune cell to bind them all: platelet contribution to neurodegenerative disease.
Rodriguez Moore G, Melo-Escobar I, Stegner D, Bracko O. Rodriguez Moore G, et al. Mol Neurodegener. 2024 Sep 27;19(1):65. doi: 10.1186/s13024-024-00754-4. Mol Neurodegener. 2024. PMID: 39334369 Free PMC article. Review.
Altering Brain Amyloidosis by Intra-Lingual and Extra-Nasal Exposure of Aβ Aggregates.
Gamez N, Bravo-Alegria J, Huang Y, Perez-Urrutia N, Dongarwar D, Soto C, Morales R. Gamez N, et al. Cells. 2022 Oct 31;11(21):3442. doi: 10.3390/cells11213442. Cells. 2022. PMID: 36359840 Free PMC article.
The Role of Circulating Aβ Seeds in the Progression of Cerebral Amyloidosis.
Gamez N, Morales R. Gamez N, et al. Neurosci Insights. 2022 Sep 15;17:26331055221123072. doi: 10.1177/26331055221123072. eCollection 2022. Neurosci Insights. 2022. PMID: 36158163 Free PMC article.
Preventive and therapeutic reduction of amyloid deposition and behavioral impairments in a model of Alzheimer's disease by whole blood exchange.
Urayama A, Moreno-Gonzalez I, Morales-Scheihing D, Kharat V, Pritzkow S, Soto C. Urayama A, et al. Mol Psychiatry. 2022 Oct;27(10):4285-4296. doi: 10.1038/s41380-022-01679-4. Epub 2022 Jul 15. Mol Psychiatry. 2022. PMID: 35835859 Free PMC article.
Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin.
Zhou AL, Sharda N, Sarma VV, Ahlschwede KM, Curran GL, Tang X, Poduslo JF, Kalari KR, Lowe VJ, Kandimalla KK. Zhou AL, et al. J Alzheimers Dis. 2022;85(3):1031-1044. doi: 10.3233/JAD-215128. J Alzheimers Dis. 2022. PMID: 34924382 Free PMC article.

Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions - PubMed (original) (raw)